抗疏健骨颗粒治疗原发性骨质疏松症临床观察中医骨伤科学专业毕业论文.docxVIP

抗疏健骨颗粒治疗原发性骨质疏松症临床观察 has increased slightly, but the difference is not obvious (P 0.05). 3, source sex of bone alkaline phosphatase (the control group, treatment group without similar between the two groups before treatment (P 0.05), after 6 months of treatment compared with before taking the medicine serum alkaline phosphatase visible reduction in treatment group than control, significant difference comparing the two groups (P 0.05), with statistical significance. Serum osteocalcin in the control group, treatment group before treatment, two groups have no difference (P 0.05); After 6 months of treatment compared with before taking the medicine serum osteocalcin, treatment group improved more obviously, both differences (P 0.05), with statistical significance. 4, the treatment group in addition to the two people concurrent symptoms improve constipation and give the corresponding processing, the rest two no adverse reaction (P 0.05). Conclusion：Hydrophobic resistance JianGu granule can obviously improve clinical symptoms in patients with primary osteoporosis, and the impact on bone mineral density, the change is not obvious, hydrophobic resistance JianGu granule treatment of primary osteoporosis curative effect more precise, deserves further research. Key words: Primary osteoporosis; Resistance to hydrophobic JianGu particles; Clinical observation Author: Yao Yi-hao Tutor: Shi Chuan-dao 5 目 录 第一章 引 言 1 第二章 文献研究 2 1 祖国医学对骨质疏松症的文献研究 2 1.1 祖国医学对骨质疏松症病因病机的认识 2 1.1.1 肾虚因素 2 1.1.2 脾虚因素 2 1.1.3 血瘀因素 3 1.2 祖国医学对骨质疏松症辩证论治与分型 3 2 现代医学对骨质疏松的认识 4 2.1 现代医学对骨质疏松的发病机制研究 4 2.2 现代医学对骨质疏松症的分类4 2.3 骨质疏松症的诊断 4 2.4 骨质疏松的治疗5 第三章 临床研究5 1 临床资料5 2 研究设计6 3 研究方法6 4 诊断标准6 5 纳入标准7 6 病例排除标准 7 7 观察指标8 8 疗效评定标准 8 9 统计方法8 10 结果 8 第四章 讨论 10 1.抗疏健骨颗粒治疗原发性骨质疏松症的理论依据 10 2.抗疏健骨颗粒的组方原理与现代药理研究10 3 疗效性分析12 4 结论 13 5 存在的问题13 第五章 结语 14 参考文献 15 附录19 致 谢 22 第一章 引 言 随着人类寿命的延长，人口老龄化越趋明显，骨质疏松症的患病率也逐渐上升， 我国老年人骨质疏松的患病率女性为 90%，男性为 61%，在全世